UNITED STATES MEDICAL ENZYMES MARKET FORECAST 2022-2028

 

TABLE OF CONTENTS

1.     RESEARCH SCOPE & METHODOLOGY   

1.1. STUDY OBJECTIVES     

1.2. SCOPE OF STUDY        

1.3. METHODOLOGY 

1.4. ASSUMPTIONS & LIMITATIONS        

2.     EXECUTIVE SUMMARY        

2.1. MARKET SIZE & ESTIMATES   

2.2. COUNTRY SNAPSHOT

2.3. COUNTRY ANALYSIS

2.4. KEY GROWTH ENABLERS

2.5. KEY CHALLENGES        

3.     KEY ANALYTICS        

3.1. IMPACT OF COVID-19 ON MEDICAL ENZYMES MARKET

3.2. KEY MARKET TRENDS  

3.3. PORTER’S FIVE FORCES ANALYSIS 

3.3.1. BUYERS POWER   

3.3.2. SUPPLIERS POWER        

3.3.3. SUBSTITUTION     

3.3.4. NEW ENTRANTS   

3.3.5. INDUSTRY RIVALRY        

3.4. OPPORTUNITY MATRIX

3.5. PESTLE ANALYSIS – UNITED STATES

3.6. VALUE CHAIN ANALYSIS         

3.6.1. RESEARCH AND DEVELOPMENT        

3.6.2. OPERATIONS        

3.6.3. OUTBOUND LOGISTICS  

3.7. KEY BUYING CRITERIA 

3.7.1. COST

3.7.2. QUALITY     

3.7.3. APPLICATION        

4.     MARKET BY TYPE      

4.1. HYDROLASE       

4.1.1. HYALURONIDASE  

4.1.2. LYSOZYMES

4.1.3. OTHER HYDROLASES ENZYMES        

4.2. THROMBOLYTIC 

4.2.1. STREPTOKINASE  

4.2.2. UROKINASE

4.2.3. OTHER THROMBOLYTIC ENZYMES    

4.3. DIGESTIVE ENZYME     

4.3.1. LACTASE     

4.3.2. L-ASPARAGINASE 

4.3.3. OTHER DIGESTIVE ENZYMES   

4.4. ENDONUCLEASE

4.4.1. BENZONASE

4.4.2. OTHER ENDONUCLEASES        

5.     MARKET BY APPLICATION  

5.1. DISEASE TREATMENT  

5.2. DIAGNOSTIC TOOLS    

5.3. BIOMEDICAL RESEARCH        

5.4. OTHER APPLICATIONS 

6.     COMPETITIVE LANDSCAPE 

6.1. KEY STRATEGIC DEVELOPMENTS   

6.1.1. MERGERS & ACQUISITIONS     

6.1.2. PRODUCT LAUNCHES & DEVELOPMENTS    

6.1.3. PARTNERSHIPS & AGREEMENTS       

6.1.4. BUSINESS EXPANSIONS & DIVESTITURES   

6.2. COMPANY PROFILES             

6.2.1. CODEXIS               

6.2.2. DSM

6.2.3. DUPONT                          

6.2.4. NOVOZYMES

6.2.5. NOVUS        

6.2.6. THERMO FISHER SCIENTIFIC

  

LIST OF TABLES

 

TABLE 1: MARKET SNAPSHOT - MEDICAL ENZYMES       

TABLE 2: MEDICAL APPLICATION OF VARIOUS ENZYMES        

TABLE 3: APPLICATIONS OF ENZYMES IN PHARMACEUTICALS INDUSTRY  

TABLE 4: UNITED STATES MEDICAL ENZYMES MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)     

TABLE 5: UNITED STATES MEDICAL ENZYMES MARKET, BY TYPE, FORECAST YEARS, 2022-2028 (IN $ MILLION)      

TABLE 6: UNITED STATES MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 7: UNITED STATES MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, FORECAST YEARS, 2022-2028 (IN $ MILLION)  

TABLE 8: UNITED STATES MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 9: UNITED STATES MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, FORECAST YEARS, 2022-2028 (IN $ MILLION)  

TABLE 10: UNITED STATES MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 11: UNITED STATES MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, FORECAST YEARS, 2022-2028 (IN $ MILLION)            

TABLE 12: UNITED STATES MEDICAL ENZYMES MARKET, BY ENDONUCLEASE ENZYME, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 13: UNITED STATES MEDICAL ENZYMES MARKET, BY ENDONUCLEASE ENZYME, FORECAST YEARS, 2022-2028 (IN $ MILLION)            

TABLE 14: UNITED STATES MEDICAL ENZYMES MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)     

TABLE 15: UNITED STATES MEDICAL ENZYMES MARKET, BY APPLICATION, FORECAST YEARS, 2022-2028 (IN $ MILLION)                 

TABLE 16: LIST OF MERGERS & ACQUISITIONS    

TABLE 17: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS  

TABLE 18: LIST OF PARTNERSHIPS & AGREEMENTS      

TABLE 19: LIST OF BUSINESS EXPANSIONS & DIVESTITURES  

 

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS      

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS     

FIGURE 3: OPPORTUNITY MATRIX    

FIGURE 4: PESTLE ANALYSIS  

FIGURE 5: VALUE CHAIN ANALYSIS   

FIGURE 6: KEY BUYING CRITERIA     

FIGURE 7: UNITED STATES MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY TYPE, IN 2021 

FIGURE 8: UNITED STATES MEDICAL ENZYMES MARKET, BY HYDROLASE, 2022-2028 (IN $ MILLION)         

FIGURE 9: UNITED STATES MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY HYDROLASE ENZYME, IN 2021     

FIGURE 10: UNITED STATES MEDICAL ENZYMES MARKET, BY HYALURONIDASE, 2022-2028 (IN $ MILLION)         

FIGURE 11: UNITED STATES MEDICAL ENZYMES MARKET, BY LYSOZYMES, 2022-2028 (IN $ MILLION)         

FIGURE 12: UNITED STATES MEDICAL ENZYMES MARKET, BY OTHER HYDROLASES ENZYMES, 2022-2028 (IN $ MILLION)        

FIGURE 13: UNITED STATES MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYMES, 2022-2028 (IN $ MILLION)    

FIGURE 14: UNITED STATES MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY THROMBOLYTIC ENZYME, IN 2021         

FIGURE 15: UNITED STATES MEDICAL ENZYMES MARKET, BY STREPTOKINASE, 2022-2028 (IN $ MILLION)

FIGURE 16: UNITED STATES MEDICAL ENZYMES MARKET, BY UROKINASE, 2022-2028 (IN $ MILLION)         

FIGURE 17: UNITED STATES MEDICAL ENZYMES MARKET, BY OTHER THROMBOLYTIC ENZYMES, 2022-2028 (IN $ MILLION)    

FIGURE 18: UNITED STATES MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2022-2028 (IN $ MILLION)    

FIGURE 19: UNITED STATES MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY DIGESTIVE ENZYME, IN 2021       

FIGURE 20: UNITED STATES MEDICAL ENZYMES MARKET, BY LACTASE, 2022-2028 (IN $ MILLION)         

FIGURE 21: UNITED STATES MEDICAL ENZYMES MARKET, BY L-ASPARAGINASE, 2022-2028 (IN $ MILLION)  

FIGURE 22: UNITED STATES MEDICAL ENZYMES MARKET, BY OTHER DIGESTIVE ENZYMES, 2022-2028 (IN $ MILLION)   

FIGURE 23: UNITED STATES MEDICAL ENZYMES MARKET, BY ENDONUCLEASE, 2022-2028 (IN $ MILLION)

FIGURE 24: UNITED STATES MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY ENDONUCLEASE, IN 2021   

FIGURE 25: UNITED STATES MEDICAL ENZYMES MARKET, BY BENZONASE, 2022-2028 (IN $ MILLION)         

FIGURE 26: UNITED STATES MEDICAL ENZYMES MARKET, BY OTHER ENDONUCLEASES, 2022-2028 (IN $ MILLION)        

FIGURE 27: UNITED STATES MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2021        

FIGURE 28: UNITED STATES MEDICAL ENZYMES MARKET, BY DISEASE TREATMENT, 2022-2028 (IN $ MILLION)       

FIGURE 29: UNITED STATES MEDICAL ENZYMES MARKET, BY DIAGNOSTIC TOOLS, 2022-2028 (IN $ MILLION)      

FIGURE 30: UNITED STATES MEDICAL ENZYMES MARKET, BY BIOMEDICAL RESEARCH, 2022-2028 (IN $ MILLION)         

FIGURE 31: UNITED STATES MEDICAL ENZYMES MARKET, BY OTHER APPLICATIONS, 2022-2028 (IN $ MILLION)   

 

KEY FINDINGS

The United States medical enzymes market is evaluated to rise with a CAGR of 6.43% across the forecasted period. While the base year regarded for the studied market is 2021, the estimated years are from 2022 to 2028. The country’s market growth is mainly ascribed to increasing consciousness about health and personal care, technological developments and innovations, and extensive research activities linked to medical enzymes.

 

Get more Insights into the United States Medical Enzymes Market:

https://inkwoodresearch.com/reports/united-states-medical-enzymes-market/

 

MARKET INSIGHTS

Enzymes are characterized as biocatalysts with the potential to alter the rate of reaction. On the other hand, it also produces the desired results in biological reactions. Medical enzymes are primarily utilized to eliminate disease-causing microorganisms, diagnose certain diseases, and promote wound healing. Moreover, enzyme technology is further being employed for the treatment of major conditions, such as cancer, lysosomal ailments, and metabolic diseases.

The presence of top players operating in the United States plays a vital role in fueling the country’s medical enzymes market. In this regard, the partnerships, collaborations, and product launches initiated by these companies are essential for the country’s market growth, as well. For example, Nestle Health Science and Codexis partnered for the discovery of novel enzyme therapies. The collaboration primarily focused on the treatment of gastrointestinal disorders. Likewise, Codexis further extended its partnership with Tate and Lyle, a global supplier of food and beverage ingredients. As a result, these factors are anticipated to proliferate the medical enzymes market growth in the United States during the forecast years.

 

COMPETITIVE INSIGHTS

Key players operating in the market are Novus, DSM, Thermo Fisher Scientific, etc.

 

Our report offerings include:

·       Explore key findings of the overall market

·       Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)

·       Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions

·       Market Segmentation cater to a thorough assessment of key segments with their market estimations

·       Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share

·       Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.

·       Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.

·       Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

 

SEGMENTATION

1.     CODEXIS                   

2.     DSM

3.     DUPONT                    

4.     NOVOZYMES

5.     NOVUS  

6.     THERMO FISHER SCIENTIFIC